Pure Global
NCT05836909

Regulation of Lipid Metabolism in Guangzhou Individuals With Dyslipidemia by Red Yeast Rice, Phytosterol Esters and Lycopene

A Randomized, Double-blind, Placebo-controlled Trial of Using Red Yeast Rice, Phytosterol Esters and Lycopene in Combination for Regulating Lipid Metabolism of Guangzhou Individuals With Dyslipidemia
Lili Yang·ClinicalTrials.gov·dietary supplementEnrolling by invitation
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Hypercholesterolemia
Drug/Device/Intervention
Swisse plus cholesterol capsule
Study type
Interventional
Intervention type
dietary supplement
Sponsor & location
Primary sponsor
Lili Yang
Funder
Sun Yat-sen University
Location
Guanzhou, China
Timeline & enrollment
Phase
N/A
Start date
May 01, 2023
End date
Apr 30, 2024
Enrollment
80 participants
Primary outcome

Change in levels of total cholesterol

Summary

The objective of this study is to evaluate the effect of using red yeast rice, phytosterol
 esters and lycopene in combination for 12 weeks on improving the glycolipid metabolism of
 Guangzhou individuals with dyslipidemia. Our hypothesis is that when compared with placebo,
 red yeast rice, phytosterol esters and lycopene together as supplements would lead to greater
 improvements in lipid metabolism (including lipid profiles and parameters ) in participants
 after 12 weeks.

ICD-10 classifications
Pure hypercholesterolaemiaLipoprotein deficiencyHyperglycaemia, unspecifiedDisorders of lipoprotein metabolism and other lipidaemiasOther disorders of lipoprotein metabolism
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05836909
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT05836909 through Pure Global AI's free database. This phase not specified trial is sponsored by Lili Yang and is currently Enrolling by invitation. The study focuses on Hypercholesterolemia. Target enrollment is 80 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.